Answers are grounded in this paper and cite their sources.
The depth of molecular response achieved with tyrosine kinase inhibitor (TKI) therapy in patients with chronic myeloid leukemia (CML) may improve the long-term outcome. Among patients who achieve c...
No takes yet. Share an insight, caveat, or question.
Maiti et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: